Ticker: PCSA

Company: Processa Pharmaceuticals, Inc.

Person: Patrick Lin, officer

Transaction date: April 30, 2026

Reporting date: May 1, 2026

Average share price: 2.69

Bought 1511.0 shares for 4064.59